纵隔子宫宫腔镜子宫纵隔切除术与期待治疗的随机对照试验
这项国际多中心开放标签随机对照试验纳入80例纵隔子宫合并不孕、流产或早产史的女性,比较宫腔镜子宫纵隔切除术与期待治疗。结果显示,切除组12个月内存活出生率为31%(12/39),期待组为35%(14/40),相对风险0.88(95%CI 0.47-1.65),手术未改善生殖结局,且发生1例子宫穿孔。
要点
- 纵隔子宫女性行宫腔镜纵隔切除术未提高12个月内活产率。
- 切除组活产12/39(31%),期待组14/40(35%),RR 0.88(95%CI 0.47-1.65)。
- 手术组发生1例子宫穿孔(1/39=2.6%),需权衡手术风险。
核心结论
- 宫腔镜子宫纵隔切除术不改善纵隔子宫女性的生殖结局。
研究设计与样本
- 国际多中心开放标签随机对照试验,在荷兰、英国、美国、伊朗10个中心于2010年10月至2018年9月开展。
- 纳入80例纵隔子宫合并不孕、流产或早产史的女性,随机分配至纵隔切除术组(n=40)或期待治疗组(n=40)。
- 主要结局为随机化后12个月内受孕并活产,定义为妊娠24周后活胎分娩;按意向性分析计算相对风险及95%CI。
主要发现
- 纵隔切除术组活产12/39(31%),期待治疗组活产14/40(35%)。
- 相对风险(RR)为0.88(95%CI 0.47-1.65)。
- 手术组发生1例子宫穿孔(1/39=2.6%)。
临床怎么用
- 对于纵隔子宫合并不孕、流产或早产史的女性,不应常规推荐宫腔镜纵隔切除术以改善活产率。
- 临床决策时应告知患者手术并未显示生殖获益,且存在子宫穿孔等手术风险。
局限性
- 尽管为大型国际试验,样本量仍有限,且招募周期长。
- 手术技术随时间无根本性变化,作者认为后者临床意义有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does septum resection improve reproductive outcomes in women with a septate uterus? SUMMARY ANSWER: Hysteroscopic septum resection does not improve reproductive outcomes in women with a septate uterus. WHAT IS KNOWN ALREADY: A septate uterus is a congenital uterine anomaly. Women with a septate uterus are at increased risk of subfertility, pregnancy loss and preterm birth. Hysteroscopic resection of a septum may improve the chance of a live birth in affected women, but this has never been evaluated in randomized clinical trials. We assessed whether septum resection improves reproductive outcomes in women with a septate uterus, wanting to become pregnant. STUDY DESIGN, SIZE, DURATION: We performed an international, multicentre, open-label, randomized controlled trial in 10 centres in The Netherlands, UK, USA and Iran between October 2010 and September 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women with a septate uterus and a history of subfertility, pregnancy loss or preterm birth were randomly allocated to septum resection or expectant management. The primary outcome was conception leading to live birth within 12 months after randomization, defined as the birth of a living foetus beyond 24 weeks of gestational age. We analysed the data on an intention-to-treat basis and calculated relative risks with 95% CI. MAIN RESULTS AND THE ROLE OF CHANCE: We randomly assigned 80 women with a septate uterus to septum resection (n = 40) or expectant management (n = 40). We excluded one woman who underwent septum resection from the intention-to-treat analysis, because she withdrew informed consent for the study shortly after randomization. Live birth occurred in 12 of 39 women allocated to septum resection (31%) and in 14 of 40 women allocated to expectant management (35%) (relative risk (RR) 0.88 (95% CI 0.47 to 1.65)). There was one uterine perforation which occurred during surgery (1/39 = 2.6%). LIMITATIONS, REASONS FOR CAUTION: Although this was a major international trial, the sample size was still limited and recruitment took a long period. Since surgical techniques did not fundamentally change over time, we consider the latter of limited clinical significance. WIDER IMPLICATIONS OF THE FINDINGS: The trial generated high-level evidence in addition to evidence from a recently published large cohort study. Both studies unequivocally do not reveal any improvements in reproductive outcomes, thereby questioning any rationale behind surgery. STUDY FUNDING/COMPETING INTEREST(S): There was no study funding. M.H.E. reports a patent on a surgical endoscopic cutting device and process for the removal of tissue from a body cavity licensed to Medtronic, outside the scope of the submitted work. H.A.v.V. reports personal fees from Medtronic, outside the submitted work. B.W.J.M. reports grants from NHMRC, personal fees from ObsEva, personal fees from Merck Merck KGaA, personal fees from Guerbet, personal fees from iGenomix, outside the submitted work. M.G. reports several research and educational grants from Guerbet, Merck and Ferring (location VUMC) outside the scope of the submitted work. The remaining authors have nothing to declare. TRIAL REGISTRATION NUMBER: Dutch trial registry: NTR 1676. TRIAL REGISTRATION DATE: 18 February 2009. DATE OF FIRST PATIENT’S ENROLMENT: 20 October 2010.
引用
- Rikken JFW, Kowalik CR, Emanuel MH, et al. Septum resection versus expectant management in women with a septate uterus: an international multicentre open-label randomized controlled trial. Hum Reprod. 2021. PMID: 33793794. doi:10.1093/humrep/deab037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。